Patients will no longer need to provide blood test results before they can get clozapine prescriptions filled, according to ...

TMS of Central Florida, a leading treatment center in Brandon, is offering cutting-edge therapy to help local residents ...

Ketamine advertisements are popping up all around us. With few regulations in place, might we be witnessing another opioid ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

Probationary employees across the FDA received notices Saturday evening that their jobs were being eliminated, according to three FDA staffers who spoke to The Associated Press on condition of ...

A new study has found that adults with a history of depression develop long-term physical health conditions about 30% faster than those without depression. The research, published on February 13 ...

It's time to think of depression as a 'whole body' disease, researchers say THURSDAY, Feb. 13, 2025 (HealthDay News) -- Depression hits the whole body, speeding the onset of long-term physical ills as ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator.

A researcher is working on apps that he hopes will be able to identify signs of depression. The programs take and analyze photos of the eyes and face while someone uses the smartphone for other ...

"Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et ...

The first transplant is expected in mid-2025. Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study. "The study will evaluate patients with ...

Languages: English That has some policy experts confused about the FDA's ability to implement efficient recalls and protect Americans from foodborne illness or public health hazards. More ...